UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Systemic immunoglobulin light chain amyloidosis

Merlini, G; Dispenzieri, A; Sanchorawala, V; Schoenland, SO; Palladini, G; Hawkins, PN; Gertz, MA; (2018) Systemic immunoglobulin light chain amyloidosis. Nature Reviews Disease Primers , 4 , Article 38. 10.1038/s41572-018-0034-3. Green open access

[thumbnail of Systemic immunoglobulin light chain amyloidosis - pre-styled.pdf]
Preview
Text
Systemic immunoglobulin light chain amyloidosis - pre-styled.pdf - Accepted Version

Download (465kB) | Preview

Abstract

Systemic immunoglobulin light chain amyloidosis is a protein misfolding disease caused by the conversion of immunoglobulin light chains from their soluble functional states into highly organized amyloid fibrillar aggregates that lead to organ dysfunction. The disease is progressive and, accordingly, early diagnosis is vital to prevent irreversible organ damage, of which cardiac damage and renal damage predominate. The development of novel sensitive biomarkers and imaging technologies for the detection and quantification of organ involvement and damage is facilitating earlier diagnosis and improved evaluation of the efficacy of new and existing therapies. Treatment is guided by risk assessment, which is based on levels of cardiac biomarkers; close monitoring of clonal and organ responses guides duration of therapy and changes in regimen. Several new classes of drugs, such as proteasome inhibitors and immunomodulatory drugs, along with high-dose chemotherapy and autologous haematopoietic stem cell transplantation, have led to rapid and deep suppression of amyloid light chain production in the majority of patients. However, effective therapies for patients with advanced cardiac involvement are an unmet need. Passive immunotherapies targeting clonal plasma cells and directly accelerating removal of amyloid deposits promise to further improve the overall outlook of this increasingly treatable disease.

Type: Article
Title: Systemic immunoglobulin light chain amyloidosis
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41572-018-0034-3
Publisher version: https://doi.org/10.1038/s41572-018-0034-3
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10065475
Downloads since deposit
1,334Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item